MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase
Authors:
- 24 September 2015
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 36 (5) , 1417-1425
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 30 references indexed in Scilit:
- Radical Prostatectomy versus Observation for Localized Prostate CancerNew England Journal of Medicine, 2012
- Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 PatientsEuropean Urology, 2010
- Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder CancerCancer Research, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- Metastasis to bone: causes, consequences and therapeutic opportunitiesNature Reviews Cancer, 2002
- Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancerBJU International, 2002